Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,570.00p
   
  • Change Today:
      55.00p
  • 52 Week High: 2,715.00p
  • 52 Week Low: 1,424.00p
  • Currency: UK Pounds
  • Shares Issued: 66.54m
  • Volume: 20,973
  • Market Cap: £1,710.01m
  • RiskGrade: 128
  • Beta: 0.05

Director dealings: Genus chairman snaps up shares

By Iain Gilbert

Date: Friday 06 Sep 2024

LONDON (ShareCast) - (Sharecast News) - Genus revealed on Friday that chairman Iain Ferguson had acquired 3,500 ordinary shares in the FTSE 250-listed biotechnology group.

Ferguson, who was took over the chairman's role in July 2020, purchased the shares on Thursday at an average price of 1,763.63p each, for a total value of £61,726.91.

As of 1640 BST, Genus shares were down 1.83% at 1,714.0p.









Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Cairn Homes (cdi) (CRN)
Director name: Stanley,Michael
Amount purchased: 8,000,000 @ 1.84
Value: 13,261,261.50

Genus (GNS)
Director name: Ferguson,Iain
Amount purchased: 3,500 @ 1,763.63p
Value: £61,726.91

Insig Ai (INSG)
Director name: Wilson ,John
Amount purchased: 400,000 @ 13.06p
Value: £52,240.00

Insig Ai (INSG)
Director name: Bernstein,Richard
Amount purchased: 400,000 @ 12.69p
Value: £50,760.00

South32 Limited (di) (S32)
Director name: Warburton,Sharon
Amount purchased: 25,000 @ $3.02
Value: $39,961.91

Apax Global Alpha Limited (APAX)
Director name: Sternberg,Karl
Amount purchased: 27,800 @ 143.70p
Value: £39,948.54




Top Director Sells

Babcock International Group (BAB)
Director name: Mellors,David
Amount sold: 276,512 @ 500.58p
Value: £1,384,150.26

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 2,570.00p
Change Today 55.00p
% Change 2.19 %
52 Week High 2,715.00p
52 Week Low 1,424.00p
Volume 20,973
Shares Issued 66.54m
Market Cap £1,710.01m
Beta 0.05
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average
90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average
Income
98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 1
Sell 1
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Final Interim
Ex-Div 06-Nov-25 06-Mar-25
Paid 05-Dec-25 04-Apr-25
Amount 21.70p 10.30p

Trades for 16-Sep-2025

Time Volume / Share Price
11:01 48 @ 2,570.00p
11:01 49 @ 2,570.00p
11:01 42 @ 2,570.00p
11:01 48 @ 2,570.00p
11:01 50 @ 2,570.00p

Genus Key Personnel

CEO Jorgen Kokke
CFO Andy Russell

Top of Page